Endocrine and Metabolic Late Effects in Cancer Survivors

2区医学 Q2 Medicine

Frontiers of Hormone Research Pub Date : 2021-11-01 DOI:10.1159/isbn.978-3-318-06791-0

Francesco Felicett, E. Brignardello, H. Santen, F. Felicetti, S. Oberfield, J. Chanoine, F. Chiarelli, P. Clayton, W. Cutfield

引用次数: 0

Abstract

Subjects: Neoplasms--drug therapy | Antineoplastic Agents--adverse effects | Endocrine Glands--drug effects | Endocrine System Diseases--chemically induced Metabolic Networks and Pathways--drug

查看原文本刊更多论文

癌症幸存者的内分泌和代谢后期效应

主题：肿瘤——药物治疗|抗肿瘤药物——不良反应|内分泌腺——药物作用|内分泌系统疾病——化学诱导的代谢网络和途径——药物

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Frontiers of Hormone Research 医学-内分泌学与代谢

自引率

0.00%

发文量

期刊介绍： A series of integrated overviews on cutting-edge topics New sophisticated technologies and methodological approaches in diagnostics and therapeutics have led to significant improvements in identifying and characterizing an increasing number of medical conditions, which is particularly true for all aspects of endocrine and metabolic dysfunctions. Novel insights in endocrine physiology and pathophysiology allow for new perspectives in clinical management and thus lead to the development of molecular, personalized treatments. In view of this, the active interplay between basic scientists and clinicians has become fundamental, both to provide patients with the most appropriate care and to advance future research.